Proximal femur shape differs between subjects with lateral and medial knee osteoarthritis and controls: the Osteoarthritis Initiative☆
Keywords
Cited by (0)
- ☆
This work was supported by the following funding sources: the Center for Musculoskeletal Health at University of California, Davis School of Medicine; NIH K24 AR048841 (NEL); NIH P50 AR060752 (BLW, NEL); NIH P50 AR063043 (BLW, NEL); the University of California, Davis Building Interdisciplinary Research Careers in Women's Health Program (NIH K12HD051958) (BLW); and the Endowed Chair for Aging at University of California, Davis School of Medicine (NEL). The Osteoarthritis Initiative (OAI) is a public–private partnership comprised of 5 contracts (N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, and N01-AR-2-2262) funded by the NIH, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Pfizer, Novartis Pharmaceuticals, Merck Research Laboratories, and GlaxoSmithKline. Private sector funding for the OAI is managed by the Foundation for the NIH.